CFAP298
Cilia- and flagella-associated protein 298
Also known as: C21orf48, C21orf59, CF298_HUMAN, CILD26, DNAAF16, FBB18, FLJ20467, Kur
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P57076
- Gene
- CFAP298
- Ensembl
- ENSG00000159079
- Chromosome
- 21
- Canonical length
- 290 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules,Primary cilium transition zone,Centrosome,Basal body,Cytosol,Principal piece
OverviewNCBI Gene
This gene encodes a protein that plays a critical role in dynein arm assembly and motile cilia function. Mutations in this gene result in primary ciliary dyskinesia. Naturally occuring readthrough transcription occurs from this locus to the downstream t-complex 10 like (TCP10L) gene. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>P57076|CFAP298
1 MVLLHVKRGD ESQFLLQAPG STELEELTVQ VARVYNGRLK VQRLCSEMEE LAEHGIFLPP
61 NMQGLTDDQI EELKLKDEWG EKCVPSGGAV FKKDDIGRRN GQAPNEKMKQ VLKKTIEEAK
121 AIISKKQVEA GVCVTMEMVK DALDQLRGAV MIVYPMGLPP YDPIRMEFEN KEDLSGTQAG
181 LNVIKEAEAQ LWWAAKELRR TKKLSDYVGK NEKTKIIAKI QQRGQGAPAR EPIISSEEQK
241 QLMLYYHRRQ EELKRLEEND DDAYLNSPWA DNTALKRHFH GVKDIKWRPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CFAP298 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 66 nTPM
- cerebellum: 44 nTPM
- pituitary gland: 40 nTPM
- hypothalamus: 35 nTPM
- testis: 34 nTPM
- fallopian tube: 32 nTPM
Single-cell type
- late primary spermatocytes: 309 nCPM
- fallopian tube ciliated cells: 171 nCPM
- respiratory ciliated cells: 135 nCPM
- epididymal efferent duct ciliated cells: 128 nCPM
- endometrial ciliated cells: 101 nCPM
- early primary spermatocytes: 99 nCPM
Immune cell
- naive B-cell: 25 nTPM
- plasmacytoid DC: 24 nTPM
- T-reg: 22 nTPM
- memory B-cell: 21 nTPM
- naive CD4 T-cell: 20 nTPM
- NK-cell: 20 nTPM
Brain region
- choroid plexus: 36 nTPM
- cerebellum: 28 nTPM
- hypothalamus: 22 nTPM
- midbrain: 20 nTPM
- cerebral cortex: 19 nTPM
- hippocampal formation: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CFAP298.
Disease | AllUniProt
Conditions CFAP298 is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 26 (CILD26) MIM:615500
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 180 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Primary ciliary dyskinesia 26
- Heterotaxy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- DepMap mean gene effect
- -1.26
- DepMap dependency class
- common
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cilia- and flagella-associated protein 298
- Cilia- and flagella-associated protein 298
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CFAP298 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CFAP298 as an antibody target. Whether an autoantibody or antibody against CFAP298 could matter depends on whether native CFAP298 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CFAP298 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CFAP298 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...